Novozymes A/S (OTCMKTS:NVZMY - Get Free Report)'s stock price passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $70.26 and traded as high as $73.18. Novozymes A/S shares last traded at $72.14, with a volume of 10,632 shares trading hands.
Novozymes A/S Stock Performance
The company has a quick ratio of 1.06, a current ratio of 1.73 and a debt-to-equity ratio of 0.14. The firm has a market capitalization of $33.51 billion, a P/E ratio of 45.28, a price-to-earnings-growth ratio of 1.34 and a beta of 0.91. The company's 50 day moving average is $70.26 and its 200-day moving average is $62.42.
About Novozymes A/S
(
Get Free Report)
Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.
See Also
Before you consider Novozymes A/S, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novozymes A/S wasn't on the list.
While Novozymes A/S currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
